In addition, treatment with a combination of the CHK1i SRA737, gemcitabine and anti-PD-L1/anti-PD-1 increased M1 macrophages and decreased M2 macrophages in a SCLC model [22]. Here, CD274 is linked to small cell lung carcinoma.